77 results
8-K
EX-10.1
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
.
SECTION 6.ENGAGEMENT TERM. The Placement Agent’s engagement hereunder will be until the earlier of the Closing Date and May 13, 2024. The date … of due diligence it deems, it necessary to terminate the engagement, the Placement Agent may do so prior to the Termination Date. The Company may
424B4
SNGX
Soligenix Inc
19 Apr 24
Prospectus supplement with pricing info
4:05pm
terms, or if any such engagement is terminated, we may be unable to enroll patients on a timely basis or otherwise conduct our trials in the manner
8-K
EX-99.1
SNGX
Soligenix Inc
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
this second study will both substantiate and improve upon these results. Given our extensive engagement with the CTCL community, our esteemed Medical
DEFA14A
y65gf kkzyq79u9
15 Sep 23
Additional proxy soliciting materials
4:10pm
8-K
gasxtb8x25f8d mibs
15 Sep 23
Changes in Registrant's Certifying Accountant
4:05pm